Aconride MP 2mg/500mg/15mg Tablet SR
Marketer
Aconwell Pharma Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Aconride MP 2mg/500mg/15mg Tablet SR
Glycemia-Control 2/500/15 SR tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It promotes efficient insulin use, consequently reducing blood sugar. Dosage and duration for Glycemia-Control 2/500/15 SR tablets should strictly adhere to your physician's instructions. Administer with food to mitigate gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic agents, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it may heighten the risk of side effects.
Primary Ingredients of Aconride MP 2mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Aconride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Aconride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Aconride MP 2mg/500mg/15mg Tablet SR whole; do not chew, crush, or fracture it. Take this extended-release tablet with a meal.
Common Side effects of Aconride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Aconride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Aconride MP 2mg/500mg/15mg Tablet SR should be swallowed whole; do not break, crush, or chew it. Administer this medication with a meal.
How Aconride MP 2mg/500mg/15mg Tablet SR works:
Aconride MP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Aconride MP 2mg/500mg/15mg SR Tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Aconride MP 2mg/500mg/15mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Aconride MP 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Aconride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. The medication is contraindicated for individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Aconride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Aconride MP 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Aconride MP 2mg/500mg/15mg Tablet SR :
Should you forget to take your Aconride MP 2mg/500mg/15mg Tablet SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Never take more than the prescribed dose.
Facts to Know About Aconride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently